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Function of human renin proximal promoter DNA. An understanding
of the mechanisms involved in the control of the human renin promoter
have been hampered and confounded in work to date because of
deficiencies in material available and experimental design. The promoter
appears to be weak and a good cell model is lacking. Chorio-decidual
cultures have been used since these have high renin synthesis, are readily
available and grow well in culture. They suffer, however, from phenotypic
variability and do not transfect well in transient expression analyses.
Recent evidence suggests that 2.6 kb of proximal 5'-flanking DNA is
unable to induce native promoter activity under basal conditions. Exper-
iments in which an exogenous enhancer was introduced have raised the
possibility that an endogenous enhancer residing outside of the 2.6 kb
5'-flanking region could be required. Cell-type specific factors also appear
to be needed. The proximal flanking DNA does, however, appear to be
capable of conferring activity on the promoter in chorio-decidual cells
under stimulated conditions, suggesting that factors so activated may have
considerable importance. Evidence suggests that forskolin-responsive
signal transduction pathways may lead cyclic AMP responsive element
(CRE) binding protein (CREB) to act on a CRE at —222 in the proximal
REN promoter DNA. Activation of the mouse promoter by cAMP
appears to involve a different element, however. Furthermore, overall
control of renin synthesis is likely to involve post-transcriptional mecha-
nisms as well. Thus, despite being the first cardiovascular gene to be
cloned, much more work is required before the control of the human renin
gene is fully understood.
Following the cloning of the human renin gene in 1983 [1, 2]
attempts have been made to delineate the mechanisms involved in
control of promoter activity by analyzing the function of the DNA
within a few kilobasepairs immediately upstream, since such DNA
in other genes generally exerts a major influence on transcrip-
tional activity. The most common method of identification of
DNA control elements involves transient expression analyses, in
cultured cells, of fragments of proximal promoter DNA coupled
to a reporter gene, such as that which encodes chloramphenicol
acetyl transferase (CAT). In the absence of cognate renin-
synthesizing juxtaglomerular cell line(s), attention has been di-
rected at cells of the human chorionic placental membrane, since
these are an abundant souce of renin [3].
Transient expression analyses in JEG-3 cells
Although placental membrane cells grow well in culture and are
readily available, they obviously differ for different deliveries.
Being phenotypically homogenous, immortalized cell lines are
preferred over primary cultures. Thus the choriocarcinoma line of
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JEG-3 cells seemed to be a good choice in initial studies [4, 5]. It
is now known, however, that the assumption that these cells would
be representative of a renin-synthesizing cell was unfounded and
that it is not chorion, but the decidual cells that remain attached
to it after delivery, that are the true source of renin in placental
membranes [6]. Moreover, by reverse transcriptase polymerase
chain reaction, it has since been shown directly that JEG-3 cells do
not contain renin mRNA [7]. Thus results that have been obtained
using JEG-3 cells [4, 5] may provide little if any information about
the mechanisms involved in activation of the REN promoter. In
addition the results obtained in one of these studies could be open
to conjecture owing to the experimental design. On the basis of
the CAT activities observed after transfection of various lengths
of REN promoter DNA extending up to 892 bp 5' of the
transcription start site (+ 1), in plasmid constructs that included a
truncated thymidine kinase (tk) promoter, which is active in most
cell types, Burt et al proposed the presence of positive regulatory
elements in the —892 to —583 and —453 to —149 DNA and
negative regulatory elements in the —583 to —453 and —145 to
+ 13 DNA [4]. In contrast, Smith and Morris found that REN
5'-flanking DNA fragments extending as far as 2.6 kb upstream
were unable to drive REN promoter activity [51.The former study
[4] lacked an internal control for transfection efficiency, variability
in which has been reported to be the single greatest contributor to
the spread of results seen with transient expression assays [8]. In
addition, Smith and Morris [5] did not detect the 10-fold increase
in CAT activity that Burt et al reported for their heterologous
constructs spanning nucleotides —892 to —149, but instead saw
significant repressor activity for this region. Another discrepancy
is that for a construct containing the sequence from —453 to —149
Burt et al reported a fivefold increase in CAT activity over their
heterologous promoter control [4], but for a similar construct with
the same endpoints, Smith and Morris observed no change from
pTKCAT [5]. The only construct in which Smith and Morris
observed a statistically significant increase in CAT activity
spanned nucleotides —1300 to —895, which were beyond the 5'
limit of the DNA studied by Burt and coworkers. The increase of
40% over pTKCAT activity [5]was, moreover, small and unlikely
to have any real functional significance. Since both the same cell
line and same heterologous promoter were used in each study it is
difficult to explain the differences in results observed between the
two groups except for the lack of an internal control for transfec-
tion efficiency in the case of Burt et a!. In our view such
transfected REN promoter DNA is inactive in JEG-3 cells.
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Transient expression in chorio-decidual cells under basal
conditions
The lack of a suitable, generally available immortalized cell line
has led to the use of primary cultures of chorio-decidual cells
scraped from chorion laeve of human placentas collected at term.
The cells grow well in culture and can be maintained for several
months with multiple subculture. However, both renin mRNA
and renin protein decline considerably after two to three weeks,
effectively limiting the useful life of the cultures to this time frame
[6].
Smith et al, in transient expression analyses in two to three
week chorio-decidual secondary cultures were unable to detect
CAT expression after transfection of constructs containing the
native REN promoter and various lengths of REN 5'-flanking
DNA extending 2.6 kb upstream of the gene [9]. In fact, the REN
promoter was no more active in these cells than in JEG-3 cells.
Smith et al [9] put forward a number of possibilities that could
explain these findings. One was that the constructs tested may be
lacking an enhancer necessary for efficient transcription initiation
in this system. In general, important cis-acting elements are found
within the sequences close to the transcription start site. In some
genes, however, enhancers have been found many kilobasepairs
distant. The human renin gene has a first intron of --4.5 kb that is
largely unsequenced and which displays strong interspecies ho-
mology at least in its sequenced 3' region, so making this DNA a
possible site for potential regulatory elements [5]. A further
possibility for the lack of REN promoter activity in chorio-
decidual cells may be because an essential trans-acting factor is
present in limiting amounts. Such a factor could be sufficient for
transcription from the native gene which is present in only two
copies in these diploid cells, but when large numbers of templates
are introduced in transient transfection experiments, a factor
present in low concentration would be unable to interact with all
of the templates, with the result that little to no reporter gene
activity would be observed. One approach that should address this
problem would be to co-transfect an expression vector for a factor
known to activate a variety of cellular genes, as has been done by
Seo et al [10] for HeLa cells, which do not express renin. This
involved 3 kb of REN 5 '-flanking DNA in CAT constructs and an
expression vector for the adenovirus 5 E1A protein, a generalized
activation factor implicated in cell transformation [11], and re-
sulted in an eightfold increase in CAT activity, from barely
detectable background levels, suggesting that E1A, either directly
or indirectly, was able to activate the renin promoter. It would
thus be of interest to determine whether the viral E1A gene
product is capable of inducing CAT reporter activity in chorio-
decidual cells. Smith et al have noted, however, a lack of activity
of the REN promoter in 293 cells which are rich in E1A protein
[9]. While Fukamizu et a! [12] reported that the 3 kb REN
5 '-flanking DNA conferred promoter activity in 293 cells in a
transient expression assay, they failed to show the appropriate
transfection controls and the activity that was seen was low. Taken
together, it is as yet unclear whether the inability to detect
promoter activity in transient expression assays in chorio-decidual
cultures under basal conditions is caused by the lack of a limiting
transcription factor.
Ekker, Sola and Rougeon [13], in studies of mouse renin
promoter activity, noted that the potent transcription terminator
sequence, UMS, from mouse c-myc, was able to reduce CAT
activity from their promoterless control plasmid to background,
indicating blockade of non-specific transcription initiated in the
vector sequences. This strategy has been employed in a number of
studies recently to reduce background 'noise,' and appears to be
of particular use when the promoter under investigation and/or
the signal being detected is weak. It is possible that the REN
promoter is not strong even in chorio-decidual cells, despite
relatively high renin mRNA. This is a corrollary to the point made
above concerning lack of a transcription factor resulting in
undetectable transcription. The fact that all of the homologous
promoter constructs tested by Smith et al [9] showed CAT
activities that were less than that of the promoterless control is
consistent with the presence in the REN sequences of a sequence
capable of terminating non-specific transcription initiated in
plasmid vector sequences. Indeed, at —80, there is a sequence
having strong homology to the consensus polyadenylation signal,
and this could serve such a function.
The usefulness of transient expression becomes limited when
transfection efficiency is low. This may be critical in chorio-
decidual secondary cultures which are far less efficiently trans-
fected than transformed cell lines. When the strength of the test
promoter is also low, detection of activity is dependent on the
sensitivity of the reporter gene assay. CAT assays may not be
sufficiently sensitive to detect weak promoter activity in trans-
fected chorio-decidual cells and more sensitive methods of tran-
sient expression analysis such as the luciferase assay may be
preferable in REN promoter studies. Using REN promoter-
luciferase constructs, which also contained, upstream of each, a
transcription termination cassette, Sun et al have obtained activ-
ities for the —581 to —98 DNA in the rat pituitary lactotrope cell
line, GC, that were clearly greater than the luciferase promoter-
less control [14]. In this report the combination of a relatively
efficiently transfected cell line, a sensitive reporter assay and the
upstream terminator in the constructs may have combined so that
REN promoter activity was detectable by transient expression
assay, even though GC cells do not transcribe the endogenous
gene.
Effect of exogenous enhancer on basal REN promoter activity
The viral SV4O enhancer has been shown by Ekker et al to
confer activity on mouse Ren-1 and Ren-2 promoters in a variety
of cell types, including JEG-3, that do not naturally transcribe the
renin gene [13] and led them to postulate that the inactivity of the
transfected renin promoter DNA was due to missing enhancer(s).
It should be noted, however, that despite regions of homology [4]
there are considerable differences between mouse and human
renin 5'-flanking DNA, largely arising from various DNA inser-
tions in the mouse upstream region. Moreover, in the case of
human renin promoter constructs transfected into JEG-3 cells,
Smith et a! found that introduction of SV4O enhancer did not lead
to CAT activity above the promoterless control for any of the
REN constructs tested [9], suggesting that in JEG-3 cells the SV4O
enhancer is not sufficient to confer transcriptional activity on the
REN promoter. In chorio-decidual cultures, however, they found
that the SV4O enhancer conferred activity on REN promoter
constructs with 5' deletion end-points at —895 and —145 that
were greater than promoterless control and approximately 25% of
the activity seen for the SV4O promoter. When the deletion
end-point was —2595, CAT activity was less than promoterless
control. These results could be interpreted as showing that the
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SV4O enhancer is able to confer weak transcriptional activity on
the REN promoter in chorio-decidual cells, but not JEG-3 cells, as
long as only 896 bp of DNA upstream of the transcription start
site are included. The presence of a further 1855 bp of upstream
DNA appeared to negate the transcription activating effect of the
SV4O enhancer. Their result differs from the report by Ekker et al
for mouse renin promoters in which strong CAT activity was seen in
a variety of cell types [13]. As mentioned above, one important
difference was the presence in the mouse study of the UMS
transcriptional terminator upstream of the renin 5'-fianking DNA.
Thus, at best, results with the human renin promoter and SV4O
enhancer show a weak activation of a truncated promoter in
renin-expressing cells and no activation in cells that do not express
the endogenous renin gene. This does not present a very strong
argument in support of lack of observed renin promoter activity
being due to the lack of an enhancer. It could, however, be that
the SV4O enhancer in combination with REN cis-elements may
not have the correct configuration to cause high REN promoter
activity. A putative native enhancer might, however, cause much
greater activation of the REN promoter.
REN promoter activity in chorio-decidual cells under
stimulated conditions
In contrast to the results obtained under basal conditions,
Smith et al have found that forskolin, a well-known stimulator of
renin synthesis and secretion, is able to induce a fivefold increase
in REN promoter activity in transfected chorio-decidual cells [15].
Thus a possible explanation for the lack of activity of the REN
promoter under basal conditions could be the absence of an
essential stimulus. Moreover, agents which mimic or increase
intracellular cAMP have been reported to affect the activity of
both the human [4, 161 and mouse [17, 18] renin promoters in
transient expression analyses. Smith et a! found that the DNA
element responsible was contained within the —453 to —145 DNA
[15], a region that showed positive regulatory activity in heterol-
ogous promoter constructs in chorio-decidual cells [9], where it is
of interest that cAMP-responsive elements can act as enhancers in
the basal state and so may be necessary for basal expression of a
number of genes [19—23]. In contrast, Duncan et a! [16] have
reported only a relatively small increase in CAT activity for this
DNA, although any effect could easily have been concealed by
variation in transfection efficiency, which was not corrected for in
their studies. Furthermore, prior to addition of forskolin, they did
not remove foetal calf serum, which can activate transcription by
stimulation of various serum response elements [24]. Using JEG-3
cells, which have proven useful in studies of cAMP-responsive
elements in genes expressed by this cell type [25—27], Burt et a!
reported that 8-bromo-cAMP caused a 30 to 60% induction of
CAT activity that was localized to the —149 to + 13 REN DNA [4].
However, since the constructs contained both tk and REN TATA
boxes and the transcription start site actually utilized was not
determined, their results are difficult to interpret. Their experi-
ments also suffer from the problems discussed earlier. In chorion-
derived cultures, Borensztein et a! found that forskolin produced
a threefold induction of CAT activity in a construct containing the
proximal 600 bp of REN 5'-fianking DNA [27].
Cyclic AMP response element and DNA-protein interactions
Smith et a! localized the majority of the forsko!in response to a
fragment spanning the region —249 to —162 and noted a match at
—225 to —218 to the consensus cyclic AMP response element
(CRE) [15] (Fig. 1). The forskolin-responsive region also con-
tained two partial matches to the AP-2 consensus sequence,
5CCCA/CNG/CGICG/C3' [24] (Fig. 1), but there were no
homologies to the AP-1 binding site, so excluding a role for this
protein in cAMP induction of the REN promoter. It has, however,
been suggested that AP-1 could nevertheless mediate signal
transduction arising from angiotensin II receptor stimulation,
since a tandem array of AP-1 sites placed upstream of the tk
promoter was able to induce CAT expression in response to
treatment of cultured vascular smooth muscle and hepatoma cells
with angiotensin II [29].
Band shift analyses involving the oligonucleotides REN64 and
REN36 (Fig. 1), corresponding to DNA housing the putative
CRE, have demonstrated specific binding of nuclear proteins [15].
Smith et al also observed that a consensus CRE oligonucleotide
corresponding to rat somatostatin promoter DNA formed a
complex of the same mobility as one formed with the REN
oligonucleotides. Moreover, mutations in residues known from
studies of other cAMP-responsive promoters to be critical for
binding of the CRE binding protein (CREB) were found to
disrupt REN oligonucleotide binding, so adding weight to argu-
ments for a role of the —222 to —218 DNA in binding CREB. The
findings are summarized in Figure 2, which also shows the other
oligonucleotide-protein binding observed and the fact that stable
CREB binding appeared to be dependent on a protein which
bound within the —263 to —240 region.
Since two potential AP-2 binding sites were contained within
the REN64 oligonucleotide, the possibility that AP-2 alone, or in
co-operation with CREB, was responsible for mediation of the
cAMP effect must be considered. Precedent exists, moreover, for
the cooperation of a CRE and an AP-2 site: in the cAMP and
phorbol ester inducible human proenkephalin promoter, an AP-2
site, situated 5 bp downstream from the ENKCRE-2 site, has been
shown to be necessary for the response to these two agents [30].
Although ENKCRE-2 had a perfect match with a CRE half site,
this study was able to show that purified AP-1 protein protected
this site in DNAse I footprints. Since footprinting with purified
CREB was not done, it is not known whether this factor could
protect the same region. The ENKCRE-2 site had greater homol-
ogy to the CRE half-site than to an AP-1 site, so CREB was more
likely, even though binding of AP-1 to a CRE has been seen [31].
Of the two potential AP-2 sites contained in REN64, one was in
the —263 to —240 segment that Smith et al found was necessary
for formation of the putative CREB complex; that is, it was in the
region not contained in the REN36 oligonucleotide. On the basis
of competition with the somatostatin CRE, however, it is more
likely that the DNA-protein complex seen by Smith et al repre-
sents CREB. It may be that one of the other retarded complexes
seen with REN64 was caused by AP-2, raising the interesting
possibility that both AP-2 and CREB interact to produce the
cAMP response. Confirmation of this will, however, require
DNAse I footprinting and site-directed mutagenesis to identify
the exact binding sites within the oligonucleotide.
Within REN64 there are several homologies to nuclear factor
binding sites (Fig. 1). Of these, only CREB and AP-2 have been
demonstrated to mediate a transcriptional response to cAMP.
Factors NF-1 and Spi are ubiquitious in distribution [24] and
UBP-1 is from HeLa cells [32]. Since HeLa, and JEG-3, nuclear
extract formed complexes with the REN64 oligonucleotide that
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Fig. 1. Sequence of the —263 to —203 region of the human REN 5'-flanking DNA and con-esponding oligonucleotides (REN64 and REN36) which contain
the putative cyclic AMP response element. Also shown, by patterned boxes, are homologies to transcription factor binding site consensus sequences in the
REN64 oligonucleotide.
were similar to those with chorio-decidual extracts [15], each of
these factors may reasonably be regarded as potential trans-acting
factors for this portion of REN 5'-fianking DNA. The remainder
show some tissue-specificity and their potential for interaction
with the REN sequences is less certain. PPAR and HNF-4 are
both expressed in kidney as well as liver [33, 34] and so could be
of possible interest in control of REN transcription in the kidney.
The GATA factor is not found in HeLa cell extracts [35] and
TCF-1 is expressed in thymus, but not in placenta or kidney [36],
so excluding these in REN64 binding.
Interestingly, in the pituitary lactotrope cell line GC, the
______ _____
transcription factor Pit-i appears to play a role in activation of
REN promoter activity by binding to DNA within the —74 to —65
region, which is closer to the transcription start site than discussed
above and on this basis it was proposed that members of the POU
family of transcription factors may be involved in mediation of
tissue-specifc expression of REN [14]. More work is needed to
substantiate this hypothesis.
Species differences in cAMP control of renin promoter
Cyclic AMP control has also been studied in the mouse, where
it appears that the trans-acting factors responsible for both the
cAMP response and negative regulation target the same 8 bp
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Mutant 36mers
M2 TATTCGGA
—225 —218
Fig. 2. Summacy of findings in band shift analyses which examined nuclear
protein binding to the oligonucleotides shown in Fig. 1. The putative CRE is
also shown, together with mutant oligonucleotides, Ml and M2, which
contained alterations in residues found in work with other cAMP-
responsive genes to be critical for attachment of CREB to CRE, and which
were used to establish the CRE-homology as a binding site for CREB in
REN DNA.
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footprint from DNAse I digestion [37]. This sequence, TCTCA-
CAG, at —589 to —582 in the Ren-1' 5'-flanking DNA, is not
homologous to the consensus CRE [20], but has a 7/8 match to the
chicken lysozyme silencer sequence, TCTCTCAG [38]. The cor-
responding nucleotides in the human sequence, TCCCGCAG at
—124 to —118, are in block VII of the interspecies homology [4],
and possess a match of only 5/8. Since a small forskolin response
was seen for the —145 to + 13 human DNA [15] this sequence
could mediate this. The sequence in mouse Ren-1" 5'-fianking
DNA that is equivalent to the human CRE is at —687 to —680,
which is within block VI of the interspecies homology [4]. The
mouse sequence, TAGAGTCA, while differing from the human
CRE by only one nucleotide, does not contain the half dyad
repeat, CGTCA, necessary for CREB binding [39], so explaining
its lack of importance in the cAMP response in mouse. The
element involved in cAMP induction in the mouse is novel,
perhaps necessitated by its dual role as both a CRE and a negative
regulatory element (NRE), a situation not unlike that, in an
unrelated gene, for the composite glucocorticoid response ele-
ment (GRE) which differs from the consensus GRE in acting as a
positive cAMP responsive and glucocorticoid NRE [40].
The difference in cAMP mechanisms between mouse and
human renin promoters adds to the well known gross differences
such as the 143 bp insertion, that in the duplicated mouse gene is
responsible for tissue-specific differences in gene expression, and
the 500 bp insertion common to both mouse renin genes [41—43].
The insertions could: (i) physically disrupt cis elements, as seen
for the 143 bp insertion in Ren-1", which inactivates the NRE; (ii)
provide new regulatory elements such as that responsible for
androgen regulation of transcription in the mouse genes; and (iii)
alter the spacing and juxtaposition of existing cis elements, so
altering their ability to interact with each other and the general
transcriptional machinery.
Finally, recent studies of cultured mouse juxtaglomerular cells
show that cAMP can increase renin mRNA stability [44], suggest-
ing that stimulation of renin production by cAMP may involve
both transcriptional and post-transcriptional mechanisms.
Conclusion
Control of the human renin promoter may, under basal condi-
tions, rely on cis-acting elements that reside elsewhere than the
proximal 2.6 kb of 5'-fianking DNA and tissue-specific trans-
acting factors. Under stimulated conditions, such as present after
treatment of renin-synthesizing cells with forskolin, activation of
the promoter may involve the binding of CREB to a CRE at —222
with respect to the transcription start site.
Reprint requests to Brian J. Morris, D.Sc., Molecular Biology & Hyperten-
sion Laboratory, Department of Physiology, Building F13, The University of
Sydney, New South Wales 2006 Australia.
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